Molecular Imaging Market Trends, Comprehensive Research Study, Competitive Landscape by Forecast 2027


Market Size – USD 7,058.7 Million in 2019, Market Growth - CAGR of 5.3%, Market Trends –Technological advancements in the healthcare sector

.

 The global molecular imaging market is projected to be worth USD 10.71 Billion by 2027, according to a current analysis by Emergen Research. The molecular imaging market is observing a rapid growth attributed to the rising occurrence of chronic diseases like cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

The report provides detailed insights into Molecular Imaging Market size, market trends, industry trends, consumer trends, market forecast, revenue share growth, along with ranging impacts of each driver on market size. It also provides analysis of various factors expected to restrain or limit potential growth in Molecular Imaging Market size over the forecast period, 2020–2028. The report includes profiles of major players in the In-vehicle infotainment market, strategies being employed/deployed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@  https://www.emergenresearch.com/industry-report/molecular-imaging-market

In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of Molecular Imaging Market share contribution of these countries. In addition, Molecular Imaging Market share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.

Top key vendors in Molecular Imaging Market include are:

Canon Inc., Digirad Corporation, General Electric Company, PerkinElmer Inc., Siemens Healthineers Inc., Bruker Corporation, Cardinal Health, Thermo Fisher Scientific, Advanced Accelerator Applications, and DDD-Diagnostics A/S, among others.

Emergen Research has segmented the global molecular imaging market on the basis of product type, application, end-users, and region:

Product Type Outlook (Revenue, USD Billion; 2017-2027)

Positron Emission Tomography

Single Photon Emission Computed Tomography

Magnetic Resonance Imaging

Computed Tomography

Others

Application Outlook (Revenue, USD Billion; 2017-2027)

Oncology

Cardiovascular Diseases

Neurology

Respiratory Diseases

Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)

Hospitals Clinics

Ambulatory Surgical Centers

Diagnostic Centers

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/271

Region wise performance of the In-vehicle infotainment industry

In terms of Molecular Imaging Market size, North America is expected to remain dominant among the other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting Molecular Imaging Market size growth.

Asia Pacific Molecular Imaging Market size is expected to remain steady, and register fastest revenue growth rate between 2020 and 2028. Rapid revenue growth rate in countries such as China and India is attributable to rapid growth in Molecular Imaging Market size in Asia Pacific, and the trend is expected to continue going ahead.  

Continuous developments in countries in Europe is expected to support growth in regional market size over the forecast period.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

The research provides answers to the following key questions:

  • What will be the growth rate and the market size of the In-vehicle infotainment industry for the forecast period 2020-2027?
  • What are the major driving forces expected to impact the development of the Molecular Imaging Market across different regions?
  • Who are the major driving forces expected to decide the fate of the In-vehicle infotainment industry worldwide?
  • Who are the prominent market players making a mark in the Molecular Imaging Market with their winning strategies?
  • Which In-vehicle infotainment industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
  • What are the key barriers and threats believed to hinder the development of the industry?
  • What are the future opportunities in the In-vehicle infotainment market?

Why Choose Emergen Research?

  1. Strong Industry Focus
  2. Extensive Product Offerings
  3. Customer Research Services
  4. Robust Research Methodology
  5. Comprehensive Reports
  6. Latest Technological Developments
  7. Value Chain Analysis
  8. Potential Market Opportunities
  9. Growth Dynamics
  10. Quality Assurance
  11. Post-sales Support

Explore More Reports from Emergen Research:

Bioremediation Market @ https://www.emergenresearch.com/industry-report/bioremediation-market

Big Data in Healthcare Market @ https://www.emergenresearch.com/industry-report/big-data-in-healthcare-market

AI In Healthcare Market @ https://www.emergenresearch.com/industry-report/ai-in-healthcare-market

Autorefractor Market @ https://www.emergenresearch.com/industry-report/autorefractor-market

Electronic Health Records Market @ https://www.emergenresearch.com/industry-report/electronic-health-records-market

Functional Fibers Market @ https://www.emergenresearch.com/industry-report/functional-fibers-market

Multiple Sclerosis Drugs Market @ https://www.emergenresearch.com/industry-report/multiple-sclerosis-drugs-market